RLYB
Rallybio Corp
NASDAQ · Healthcare · Biotechnology · US
$15.90
+0.25%Oct 22, 2026, 18:00 UTC
Kahn Swick & Foti, LLC said it is investigating the proposed merger of Rallybio Corp and Avenzo Therapeutics, Inc., including the process leading to the transaction.
Source:Jun 1, 2026, 12:00 UTC
Rallybio Corporation agreed to acquire Avenzo Therapeutics, Inc. through a merger.
Source: